Pro Pharmaceutical (000739.SZ): Amoxicillin Clavulanic Acid Tablets Obtained Drug Registration Certificate

Zhtng Cijng APP News, Prul Pharmaceuticals (000739.SZ) announced that its wholly-owned subsidiary, Zhejiang Prul Jutai Pharmaceuticals Co., Ltd., recently received the "Drug Registration Certificate" for Amoxicillin Clavulanate Potassium Tablets issued by the National Medical Products Administration (referred to as the "Drug Administration"). This product is used to treat the following infections: Upper respiratory tract infections (including ear, nose, throat): recurrent tonsillitis, sinusitis, otitis media. Lower respiratory tract infections: acute and chronic bronchitis (especially for severe infections), lobar pneumonia, bronchopneumonia. Urinary tract infections: cystitis (especially for recurrent or complicated infections, excluding prostatitis). Skin and soft tissue infections: such as cellulitis, animal bites combined with wound infections. Oral infections: severe periodontal abscess combined with facial cellulitis.